Medical Device News Magazine

ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

ENFLONSIA is the first and only RSV preventive option for [...]

By |2025-06-26T17:48:09+00:00June 26, 2025|3rd Party Medical Device Industry News|Comments Off on ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
Go to Top